Evidence map›Paper›PMID 39968013›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Editorial: Recent advancements in RNA technologies, diagnostics, and therapeutics.

Jaimie Marie Stewart, Yaroslava G Yingling, Kirill A Afonin, Florent Hubé, Naoyuki Kataoka

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaimie Marie StewartDepartment of Bioengineering, University of California, Los Angeles, CA, United States.
Yaroslava G YinglingDepartment of Materials Science and Engineering, North Carolina State University, Raleigh, NC, United States.
Kirill A AfoninNanoscale Science Program, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC, United States.
Florent HubéLaboratoire Biologie du Développement, Institut de Biologie Paris-Seine, Transgenerational Epigenetics and Small RNA Biology, Sorbonne Université, CNRS, Paris, France.
Naoyuki KataokaLaboratory of Cellular Biochemistry, Department of Animal Resource Sciences, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.

Funding

SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responsesR35GM139587 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI AFONIN, KIRILL A · 2021 to 2025
$1.8M
NIGMS NIH HHS R35 GM139587
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circRNAmiRNARNA circuitsRNAiRNA technologiessynthetic biologytheranosticstissue engineering

Identifiers

PMID39968013
PMCPMC11832523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.